201 related articles for article (PubMed ID: 34506681)
1. Children with familial hypercholesterolemia display changes in LDL and HDL function: A cross-sectional study.
Christensen JJ; Narverud I; Ruuth M; Heier M; Jauhiainen M; Ulven SM; Bogsrud MP; Kovanen PT; Halvorsen B; Oda MN; Wium C; Retterstøl K; Öörni K; Holven KB
J Intern Med; 2021 Nov; 290(5):1083-1097. PubMed ID: 34506681
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study.
Christensen JJ; Ulven SM; Retterstøl K; Narverud I; Bogsrud MP; Henriksen T; Bollerslev J; Halvorsen B; Aukrust P; Holven KB
Atherosclerosis; 2017 Nov; 266():48-57. PubMed ID: 28963918
[TBL] [Abstract][Full Text] [Related]
3. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC
Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
7. Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and plasma lipoprotein levels in familial hypercholesterolemia.
Carmena-Ramón R; Ascaso JF; Real JT; Nájera G; Ordovás JM; Carmena R
Metabolism; 2001 Jun; 50(6):651-6. PubMed ID: 11398140
[TBL] [Abstract][Full Text] [Related]
8. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia.
Guérin M; Dolphin PJ; Talussot C; Gardette J; Berthézène F; Chapman MJ
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1359-68. PubMed ID: 7670950
[TBL] [Abstract][Full Text] [Related]
9. Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia.
Bellanger N; Orsoni A; Julia Z; Fournier N; Frisdal E; Duchene E; Bruckert E; Carrie A; Bonnefont-Rousselot D; Pirault J; Saint-Charles F; Chapman MJ; Lesnik P; Le Goff W; Guerin M
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1675-81. PubMed ID: 21527752
[TBL] [Abstract][Full Text] [Related]
10. Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia.
Orsoni A; Villard EF; Bruckert E; Robillard P; Carrie A; Bonnefont-Rousselot D; Chapman MJ; Dallinga-Thie GM; Le Goff W; Guerin M
J Lipid Res; 2012 Apr; 53(4):767-75. PubMed ID: 22338009
[TBL] [Abstract][Full Text] [Related]
11. Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life.
Nagasaka H; Miida T; Hirano K; Ota A; Yorifuji T; Takatani T; Tsukahara H; Takayanagi M; Hui SP; Kobayashi K; Chiba H
J Clin Endocrinol Metab; 2008 Mar; 93(3):779-83. PubMed ID: 18182454
[TBL] [Abstract][Full Text] [Related]
12. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
[TBL] [Abstract][Full Text] [Related]
13. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
[TBL] [Abstract][Full Text] [Related]
14. Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia.
Du Z; Li F; Jiang L; Li L; Du Y; Yu H; Luo Y; Wang Y; Sun H; Hu C; Li J; Yang Y; Jiao X; Wang L; Qin Y
BMC Med; 2023 Jul; 21(1):275. PubMed ID: 37501168
[TBL] [Abstract][Full Text] [Related]
15. Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia.
Narverud I; van Lennep JR; Christensen JJ; Versmissen J; Gran JM; Iversen PO; Aukrust P; Halvorsen B; Ueland T; Ulven SM; Ose L; Veierød MB; Sijbrands E; Retterstøl K; Holven KB
Atherosclerosis; 2015 Nov; 243(1):155-60. PubMed ID: 26386212
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country.
Chlebus K; Zdrojewski T; Gruchała M; Gałąska R; Pajkowski M; Kocejko MR; Chmara M; Pencina MJ
Am Heart J; 2019 Dec; 218():32-45. PubMed ID: 31706143
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
18. Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children.
Wiegman A; Rodenburg J; de Jongh S; Defesche JC; Bakker HD; Kastelein JJ; Sijbrands EJ
Circulation; 2003 Mar; 107(11):1473-8. PubMed ID: 12654602
[TBL] [Abstract][Full Text] [Related]
19. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.
Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S
J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077
[TBL] [Abstract][Full Text] [Related]
20. Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia.
Christensen JJ; Osnes LT; Halvorsen B; Retterstøl K; Bogsrud MP; Wium C; Svilaas A; Narverud I; Ulven SM; Aukrust P; Holven KB
Atherosclerosis; 2017 Jan; 256():67-74. PubMed ID: 28024183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
